SLV318, a novel agonist for the dopamine D2 and D3 receptor:: In vitro and in vivo neurochenical characterization

被引：0
|
作者：
Hesselink, MB
van der Neut, M
Adolfs, T
Feenstra, R
Long, S
van Scharrenburg, G
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P170
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [1] The in vivo characterization of SLV308:: A novel dopamine D2/D3 partial agonist and 5-HT1A full agonist for the treatment of Parkinson's disease
    McCreary, AC
    Johnston, L
    Glennon, J
    Rose, S
    Jackson, M
    Jenner, P
    MOVEMENT DISORDERS, 2006, 21 : S79 - S79
  • [2] The in vitro characterization of SLV308:: A novel dopamine D2/D3 partial agonist and 5-HT1A full agonist for the treatment of Parkinson's disease
    McCreary, AC
    Glennon, JG
    Reindeers, JH
    Hesselink, M
    van Scharrenburg, G
    MOVEMENT DISORDERS, 2006, 21 : S79 - S80
  • [3] In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor
    Wood, Martyn
    Ates, Ali
    Andre, Veronique Marie
    Michel, Anne
    Barnaby, Robert
    Gillard, Michel
    MOLECULAR PHARMACOLOGY, 2016, 89 (02) : 303 - 312
  • [4] IN-VIVO AND IN-VITRO CHARACTERIZATION OF R(+)-FIDA2, A NOVEL DOPAMINE D2/D3 RECEPTOR IMAGING AGENT
    VESSOTSKIE, J
    KUNG, MP
    ROMANIELLO, G
    CHUMPRADIT, S
    MCELGIN, W
    FREDERICK, D
    MALISON, RT
    KUNG, HF
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P128 - P128
  • [5] In vitro and in vivo characterization of the agonist-dependent D3 dopamine receptor tolerance property
    Cote, Samantha R.
    Kuzhikandathil, Eldo V.
    NEUROPHARMACOLOGY, 2014, 79 : 359 - 367
  • [6] Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands
    Elek, Milica
    Djokovic, Nemanja
    Frank, Annika
    Oljacic, Slavica
    Zivkovic, Aleksandra
    Nikolic, Katarina
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2021, 354 (06)
  • [7] In vitro characterisation of the high affinity D2/D3 dopamine agonist (+)PhNO
    Parker, Christine
    Clarke, K.
    Gee, A. D.
    Gee, A.
    Rabiner, E.
    NEUROIMAGE, 2006, 31 : T29 - T29
  • [8] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Paul W. Czoty
    H. Donald Gage
    Pradeep K. Garg
    Sudha Garg
    Michael A. Nader
    Psychopharmacology, 2014, 231 : 613 - 619
  • [9] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Czoty, Paul W.
    Gage, H. Donald
    Garg, Pradeep K.
    Garg, Sudha
    Nader, Michael A.
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 613 - 619
  • [10] Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets:: Mediation by D2, not D3, dopamine receptors
    Hill, Michael P.
    Ravenscroft, Paula
    McGuire, Steven G.
    Brotchie, Jonathan M.
    Crossman, Alan R.
    Rochat, Catherine
    Millan, Mark J.
    MOVEMENT DISORDERS, 2006, 21 (12) : 2090 - 2095
12345